SCHEMBL10012137

SCHEMBL10012137

CCOC(=O)C(C)CCC(=O)OCCC#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
POLB P06746 2/20 0.38
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
GAA P10253 2/20 0.33
DGKA P23743 1/20 0.33
CYP1A2 P05177 1/20 0.33
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA1A P35348 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10011627 0.94 L3MBTL1 (0.40) L3MBTL1KMT2AMEN1POLBCYP3A4
SCHEMBL10010187 0.92 ADRA2A (0.33) KMT2AMEN1DGKACYP1A2TSHR
SCHEMBL10011523 0.91 DGKA (0.38) L3MBTL1KMT2AMEN1POLBCYP3A4
SCHEMBL10011145 0.86 ADRA2A (0.32) L3MBTL1KMT2AMEN1DGKAADRA2A
SCHEMBL10012706 0.85 CYP1A2 (0.41) L3MBTL1KMT2AMEN1POLBCYP3A4
SCHEMBL10011402 0.84 MEN1 (0.41) KMT2AMEN1CYP3A4CYP2C19GAA
SCHEMBL10010859 0.84 L3MBTL1 (0.32) L3MBTL1
SCHEMBL10011484 0.83 TSHR (0.38) KMT2AMEN1TSHRKDM4ELMNA
SCHEMBL10012286 0.83 DGKA (0.37) KMT2AMEN1CYP3A4DGKACYP1A2
SCHEMBL7511223 0.82 CA1 (0.38) L3MBTL1KMT2AMEN1DGKATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9130244-B2 Nonaqueous electrolyte solution and electrochemical element using same UBE INDUSTRIES, LTD. (JP) 2015-09-08 US disclosed
EP-2908376-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2015-08-19 EP disclosed
EP-2479831-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME Ube Industries, Ltd. (JP) 2012-07-25 EP disclosed
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 L3MBTL1 3802/4885KMT2A 3003/4885MEN1 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.